Winway Health Desk
Quest Diagnostics acquires Blueprint Genetics
One of the world’s largest lab-testing companies is acquiring a Finnish firm that it said would improve genetic testing for rare and genetic diseases.
Secaucus,...
NICE shuts out AstraZeneca’s Tagrisso—and dings J&J’s Stelara, too
It’s final: England won’t be covering AstraZeneca’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutations.
The treatment has won global...
Lonza’s next CEO to be pharma or biotech vet, chairman says
Lonza’s search for a new CEO could take longer than the last leader served in that role. The Swiss CDMO says it intends to...
FDA study asks whether drug names change how consumers, docs view...
The FDA wants to know what, exactly, is in a drug name. Specifically, can a brand moniker determine how consumers and healthcare providers perceive...
Digital therapeutics can solve the greatest unmet need in behavioral healthcare:...
Our mental and behavioral health is largely determined by how the brain develops during the first few years of life when the brain is...
FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease...
FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
DUBLIN--(BUSINESS WIRE)--Jan. 21, 2020-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the...
Digital health, digital therapeutics, digital medicines – what’s in a name?
As the digital health industry gains ground, companies have bandied about all sorts of terminology. Some sell digital medicines. Others sell digital therapeutics. One...
Horizon notches blockbuster FDA approval for rare eye disease med Tepezza
Horizon Therapeutics is trying to shed its reputation as a primary care drugmaker and emerge with a brand-new life in rare diseases. Now, with...
GSK gets expedited FDA review for multiple myeloma drug
A British drugmaker said it could become the first company on the market with a multiple myeloma drug targeting a protein on the surface...
Allergan highlights strong women in new Botox ads for chronic migraine...
Migraine episodes are tough, but the women who fight through them are tougher. That’s the message from Allergan in its evolved Botox for chronic...
